Evidence map›Paper›PMID 30308206›Full record

ArticleAmerican journal of ophthalmology2019

Laboratory Results, Epidemiologic Features, and Outcome Analyses of Microbial Keratitis: A 15-Year Review From St. Louis.

Hugo Y Hsu, Benjamin Ernst, Eric J Schmidt, Rohit Parihar, Chelsea Horwood, Sean L Edelstein

Open access · greenAbstract read
In one paragraph

Article in American journal of ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Microbial Keratitis in Southern Arizona.Ophthalmic research · 2026
    Article
  6. Observational
  7. Microbial keratitis in north-western Spain: a review of risk factors, microbiological profile and resistance patterns.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Staphylococcal Enterotoxins Promote Virulence in Bacterial Keratitis.Investigative ophthalmology & visual science · 2023
    Article
  13. Review
  14. Spectrum and resistance in bacterial infections of the ocular surface in a German tertiary referral center 2009-2019.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Antimicrobial nanomedicine for ocular bacterial and fungal infection.Drug delivery and translational research · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hugo Y HsuDoheny Eye Center of UCLA, Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. Electronic address: hhsu@doheny.org.
Benjamin ErnstDepartment of Ophthalmology, Saint Louis University School of Medicine, St Louis, Missouri, USA.
Eric J SchmidtDepartment of Ophthalmology, Saint Louis University School of Medicine, St Louis, Missouri, USA.
Rohit PariharDepartment of Ophthalmology, Saint Louis University School of Medicine, St Louis, Missouri, USA.
Chelsea HorwoodDepartment of Ophthalmology, Saint Louis University School of Medicine, St Louis, Missouri, USA.
Sean L EdelsteinDepartment of Ophthalmology, Saint Louis University School of Medicine, St Louis, Missouri, USA.
Saint Louis University · USDoheny Eye Institute · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
NCATS NIH HHS UL1 TR001881
6 · The paper itself

Abstract

purposeTo evaluate the laboratory results and prognostic factors of poor clinical outcomes in microbial keratitis cases over 15 years at Saint Louis University.

designRetrospective cohort and trend study.

methodsMicrobiological and clinical information from culture-positive cases seen at Saint Louis University from 1999 to 2013 were reviewed retrospectively. Statistical analyses were used to determine microbiological and antibiotic susceptibility trends. Prognostic factors of poor clinical outcome from the literature were used to create multivariate regression models to describe our cohort.

resultsGram-positive organisms predominated (48%), followed by gram-negative organisms (34%) and fungi (16%). The most commonly isolated organism was Pseudomonas aeruginosa (21%). Oxacillin-resistant rates of Staphylococcus aureus and coagulase-negative staphylococci were 45% and 43%, respectively. Only the proportion of Pseudomonas changed significantly over time (P = .02). The only antibiotic found to lose efficacy over time was gentamicin for gram-positive organisms (P = .005). Multivariate logistic regression analyses revealed that major complications were associated with large ulcers (P < .006), fungal cases (P < .001), and comorbid ophthalmic conditions (P < .001). Poor healing was associated with large ulcers (P < .001) and fungal cases (P < .001). Lastly, poor visual outcome was associated with large ulcers (P < .01) and age ≥ 60 years (P < .02).

conclusionsIn the St Louis area, oxacillin-resistant organisms, Pseudomonas aeruginosa, and fungi are commonly recovered from microbial keratitis cases with a disproportionally high incidence. Hence, empiric antibiotic choice should reflect these trends. Special care needs to be taken for patients with large ulcers and fungal infections, as well as elderly patients with comorbid ophthalmic conditions, as these patients have worse clinical outcomes.

Indexed as

Corneal UlcerEye Infections, BacterialEye Infections, FungalAcademic Medical CentersAdultAgedAnti-Bacterial AgentsBacteriaClinical Laboratory TechniquesFemaleFollow-Up StudiesFungiHumansMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial Agents

Identifiers

PMID30308206
PMCPMC6349514
OpenAlexW2897938324

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.